References
- Akhlaghi F, Trull AK. (2002). Distribution of cyclosporin in organ transplant recipients. Clin Pharmacokinet 41:615–37
- Awortwe C, Bouic PJ, Masimirembwa CM, Rosenkranz B. (2014). Inhibition of major drug metabolizing CYPs by common herbal medicines used by HIV/AIDS patients in Africa: implications for herb-drug interactions. Drug Metab Lett 7:83–95
- Bauer R, Remiger P. (1989). TLC and HPLC analysis of alkamides in Echinacea drugs. Planta Med 55:367–71
- Behm Dillon DM, Penzak SR, Bailey Klepser T. (2004). The use of herbals by patients with HIV. Adv Pharm 2:41–60
- Bjornsson TD, Callaghan JT, Einolf HJ, et al.; Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; FDA Center for Drug Evaluation and Research (CDER). (2003). The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos 31:815–32
- Chu V, Einolf HJ, Evers R, et al. (2009). In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of America perspective. Drug Metab Dispos 37:1339–54
- Clauson KA, Santamarina ML, Rutledge JC. (2008). Clinically relevant safety issues associated with St. John's wort product labels. BMC Complement Altern Med 8:42
- de Carvalho LM, Martini M, Moreira AP, et al. (2011). Presence of synthetic pharmaceuticals as adulterants in slimming phytotherapeutic formulations and their analytical determination. Forensic Sci Int 204:6–12
- Ding X, Staudinger JL (2005). Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase a signal transduction pathway. J Pharmacol Exp Ther 312:849–56
- Fuhr U (2000). Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans. Clin Pharmacokinet 38:493–504
- Goodwin B, Hodgson E, Liddle C. (1999). The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56:1329–39
- Gorski JC, Huang SM, Pinto AP, et al. (2004). The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 75:89–100
- Guiotto P, Woelkart K, Grabnar I, et al. (2008). Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract. Phytomedicine 15:547–54
- Gurley BJ, Gardner SF, Hubbard MA, et al. (2004). In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 76:428–40
- Hewitt NJ, de Kanter R, LeCluyse E. (2007). Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry – do they comply with FDA recommendations? Chem Biol Interact 168:51–65
- Hsiao AF, Wong MD, Kanouse DE. (2003). Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients. J Acquir Immune Defic Syndr 33:157–65
- Kliewer SA, Moore JT, Wade L. (1998). An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73–82
- Lehmann JM, Mckee DD, Watson MA, et al. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016–23
- Li L, Stanton JD, Tolson AH, et al. (2009). Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor mediated pathways. Pharm Res 26:872–82
- Li TSC. (1998). Echinacea: cultivation and medicinal value. Hort Technol 8:122–9
- Maglich JM, Stoltz CM, Goodwin B, et al. (2002). Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62:638–46
- Manda VK, Dale OR, Awortwe C, et al. (2014). Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents. Front Pharmacol 5:178
- Mannel M. (2004). Drug interactions with St John’s wort: mechanisms and clinical implications. Drug Saf 27:773–97
- Moradai M, Silva E, Suter A, et al. (2011). Safety of herbal medicinal products: Echinacea and selected alkylamides do not induce CYP3A4 mRNA expression. Evid Based Complement Alternat Med 2011:213021
- Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
- Naspinski C, Gu X, Zhou GD, et al. (2008). Pregnane X receptor protects HepG2 cells from BaP-induced DNA damage. Toxicol Sci 104:67–73
- Paine MF, Hart HL, Ludington SS, et al. (2006). The human intestinal cytochrome P450 “pie”. Drug Metab Dispos 34:880–6
- Pascussi JM, Busson-Le Coniat M, Maurel P, Vilarem MJ. (2003). Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. Mol Endocrinol 17:42–55
- Penzak SR, Robertson SM, Hunt JD, et al. (2010). Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects. Pharmacotherapy 30:797–805
- Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
- Piscitelli SC, Burstein AH, Chaitt D, et al. (2000a). Indinavir concentrations and St. John’s wort. Lancet 355:547–8
- Piscitelli SC, Burstein AH, Chaitt D, et al. (2001). Indinavir concentrations and St John's wort. Lancet 14:357(9263)
- Piscitelli SC, Burstein AH, Welden N, et al. (2000b). The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 34:234–8
- Raner G, Cornelious S, Moulick K, Wang Y. (2007). Effects of herbal products and their constituents on human cytochrome P4502E1 activity. Food Chem Toxicol 45:2359–65
- Renwick AB, Surry D, Price RJ, et al. (2000). Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms. Xenobiotica 30:955–69
- Shimizu M. (2010). Interaction between food substances and the intestinal epithelium. Biosci Biotechnol Biochem 74:232–41
- SPINS Inc. (2007). Schaumburg, Echinacea Sales Report. Philadelphia
- Synold TW, Dussault I, Forman BM. (2001). The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7:584–90
- Yale SH, Glurich I. (2005). Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med 11:433–9